Challenges of sarcoidosis and its management

M Drent, ED Crouser, J Grunewald - New England Journal of …, 2021 - Mass Medical Soc
Sarcoidosis Sarcoidosis is a lung disease of unknown cause characterized by noncaseating
granulomas; the heart and nervous system may also be involved. It is often misdiagnosed; …

The occupational burden of nonmalignant respiratory diseases. An official American Thoracic Society and European Respiratory Society statement

PD Blanc, I Annesi-Maesano, JR Balmes… - American journal of …, 2019 - atsjournals.org
Rationale: Workplace inhalational hazards remain common worldwide, even though they
are ameliorable. Previous American Thoracic Society documents have assessed the …

Silicosis: an update and guide for clinicians

S Krefft, J Wolff, C Rose - Clinics in chest medicine, 2020 - chestmed.theclinics.com
There are 2 primary goals of this overview. The first is to provide an update on the already
significant body of literature on silicosis, with emphasis on emerging exposure settings and …

[HTML][HTML] Sarcoidosis: a nationwide registry-based study of incidence, prevalence and diagnostic work-up

MG Sikjær, O Hilberg, R Ibsen, A Løkke - Respiratory medicine, 2021 - Elsevier
Introduction The primary objective was to evaluate the prevalence and incidence of
sarcoidosis, and secondly, to evaluate differences in incidence by age at diagnosis, gender …

[HTML][HTML] Sarcoidosis and its relation to other immune-mediated diseases: Epidemiological insights

EV Arkema, M Rossides, YC Cozier - Journal of Autoimmunity, 2023 - Elsevier
Several epidemiological studies show a co-occurrence of sarcoidosis with other immune-
mediated diseases (IMD). There are many similarities between sarcoidosis and IMDs in their …

Characteristics and prevalence of domestic and occupational inhalational exposures across interstitial lung diseases

CT Lee, A Adegunsoye, JH Chung, IB Ventura… - Chest, 2021 - Elsevier
Background Inhalational exposures are increasingly recognized as contributing factors in
interstitial lung disease (ILD). However, the characteristics of both exposures and exposed …

Sarcoidosis-a multisystem disease.

DP Franzen, M Brutsche, J Nilsson, C Böni… - Swiss medical …, 2022 - boris.unibe.ch
Sarcoidosis is a systemic inflammatory disease, characterised by granuloma formation upon
an unknown trigger in genetically predisposed individuals. The inflammation is …

Genome-wide association study identifies multiple HLA loci for sarcoidosis susceptibility

SY Liao, S Jacobson, NY Hamzeh… - Human molecular …, 2023 - academic.oup.com
Sarcoidosis is a complex systemic disease. Our study aimed to (1) identify novel alleles
associated with sarcoidosis susceptibility;(2) provide an in-depth evaluation of HLA alleles …

Inhalational exposures in patients with fibrotic interstitial lung disease: presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis

CT Lee, ME Strek, A Adegunsoye, AW Wong… - …, 2022 - Wiley Online Library
Background and objective Inhalational exposures are a known cause of interstitial lung
disease (ILD), but little is understood about their prevalence across ILD subtypes and their …

The role of the host-microbiome and metabolomics in sarcoidosis

J Kim, S Lee, Y Moodley, L Yagnik… - … of Physiology-Cell …, 2023 - journals.physiology.org
Sarcoidosis is a complex inflammatory fibrotic disease that affects multiple organ systems. It
is characterized by the infiltration of lymphocytes and mononuclear phagocytes, which form …